• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Digital innovation in clinical trials: Strategic implications for drug and device development


In this panel discussion, industry experts Dr. Scott Gottlieb, Joel Haspel, and Shwen Gwee explore the effects and evolution of digital innovation, as well as the regulatory stance on the acceleration and adoption of digital tools in clinical trials.

Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Corevitas Clinical Trials